Valuation Clinuvel Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. 10:10:26 18/09/2026 +04			5-day change	1st Jan Change
8.370 ^AUD	+2.57%		+4.10%	-32.83%

09-09	Clinuvel Pharmaceuticals Ltd Completes Development Of Zerokin Single-Use Administration Device For Controlled-Release Formulations	CI
09-08	Clinuvel Pharmaceuticals Completes Development of Proprietary Drug Delivery Device	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	733.7	883.5	769.8	520.3	518.4	422.1	-	-
Change	-	20.4%	-12.87%	-32.41%	-0.36%	-18.58%	-	-
Enterprise Value (EV) ¹	612.2	726.6	585.9	296.2	309.1	138.2	104.8	65.33
Change	-	18.69%	-19.37%	-49.45%	4.37%	-55.3%	-24.18%	-37.65%
P/E	36.8x	30.3x	22x	14.5x	15.4x	11.8x	11.1x	7.78x
PBR	5.84x	5.37x	3.79x	2.17x	1.91x	1.38x	1.25x	1.08x
PEG	-	0.6x	1.2x	5.06x	-2.21x	1.83x	1.99x	0.2x
Capitalization / Revenue	11.2x	11.3x	8.73x	5.48x	5.51x	4.45x	4.1x	3.07x
EV / Revenue	9.32x	9.28x	6.64x	3.12x	3.29x	1.46x	1.02x	0.48x
EV / EBITDA	16.4x	19.5x	12x	6.84x	8.09x	3.64x	2.51x	1.05x
EV / EBIT	16.7x	20x	12.3x	7.03x	8.31x	3.75x	2.58x	1.08x
EV / FCF	15.5x	20.2x	18.6x	7.26x	8.76x	3.77x	2.59x	1.13x
FCF Yield	6.44%	4.94%	5.37%	13.8%	11.4%	26.5%	38.7%	88.8%
Dividend per Share ²	0.04	0.05	0.05	0.05	0.05	0.0547	0.065	0.0913
Rate of return	0.27%	0.28%	0.33%	0.48%	0.49%	0.65%	0.78%	1.09%
EPS ²	0.403	0.591	0.698	0.718	0.668	0.7112	0.7508	1.076
Distribution rate	9.93%	8.46%	7.16%	6.96%	7.49%	7.69%	8.66%	8.49%
Net sales ¹	65.72	78.32	88.18	95.02	94.02	94.86	103	137.3
EBITDA ¹	37.44	37.2	48.95	43.3	38.2	37.94	41.81	61.94
EBIT ¹	36.68	36.41	47.81	42.12	37.21	36.85	40.62	60.47
Net income ¹	20.88	30.6	35.64	36.17	33.92	36.02	38.1	54.47
Net Debt ¹	-121.5	-156.8	-183.9	-224.1	-209.3	-283.9	-317.3	-356.8
Reference price ²	14.850	17.880	15.370	10.380	10.280	8.370	8.370	8.370
Nbr of stocks (in thousands)	49,410	49,410	50,083	50,124	50,428	50,428	-	-
Announcement Date	30/08/22	29/08/23	28/08/24	27/08/25	27/08/26	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CLINUVEL PHARMACEUTICALS LIMITED	11.77x	1.46x	3.64x	0.65%	300M
REGENERON PHARMACEUTICALS, INC.	18.18x	4.21x	9.88x	0.5%	78.35B
MODERNA, INC.	-18.37x	27.54x	-17.88x	-.--%	61.52B
CSL LIMITED	20.55x	4.37x	13.55x	2.4%	59.78B
SAMSUNG BIOLOGICS CO.,LTD.	34.06x	11.59x	22.22x	-.--%	46.53B
UCB	20.79x	4.6x	13.1x	0.7%	45.5B
BIOGEN INC.	35.15x	3.52x	13.21x	-.--%	31.84B
INCYTE CORPORATION	55.92x	3.56x	27.61x	-.--%	25.4B
INNOVENT BIOLOGICS, INC.	63.43x	6.8x	40.64x	-.--%	21.43B
SWEDISH ORPHAN BIOVITRUM AB	23.43x	5.03x	13.09x	-.--%	15.77B
Average	26.49x	7.27x	13.90x	0.43%	38.64B
Weighted average by Cap.	21.54x	8.96x	11.16x	0.56%